Wet AMD and DME Drug Development Summit | Virtual Event | April 13-15, 2021

Temas de la conferencia
The Wet AMD and DME Drug Development Summit comes at a critical juncture, as the research community progresses novel drug candidates targeting angiogenesis-driven disease, and a pandemic further exposes the treatment limitations for a global aging population.

The treatment landscape for Wet Age-Related Macular Degeneration (wet AMD) and Diabetic Macular Edema (DME) has dramatically changed since the first anti-VEGF therapies were approved for ocular neovascularization.

Organizador profesional (PCO)
Hanson Wade

Observaciones
Brochure: https://go.evvnt.com/722199-2?pid=4832

Speakers: Casey Kopczynski, Chief Scientific Officer, Aerie Pharmaceuticals, Kevin Peters, Chief Scientific and Medical Officer and Senior Vice President, Aerpio Therapeutics and more.

https://go.evvnt.com/722199-0?pid=4832

Ms. Stephanie Nketia